Telegram-
Loading indices

KOSPI · 0120G0

Samyang Biopharm

Market cap₩334B
PER24.13×
PBR1.40×
Foreign ownership3.99%

Pension summary

as of Oct 19
streakNone
5D+₩10M
20D-₩650M
60D-₩2.2B
Foreign 20D+₩2.2B
Inst. 20D-₩1.3B

Pension daily net buy

-

Cumulative net buying by investor

-
선택 기간의 net buy Total · ₩100M
DateClosePension fundsForeignInstitutionsRetail
10/1944,900–+₩320M-₩390M+₩70M
10/1643,100–+₩780M-₩190M-₩430M
10/1540,150₩0M+₩260M-₩190M-₩90M
10/1443,050+₩10M+₩110M+₩120M-₩230M
10/1343,150₩0M+₩40M-₩110M+₩30M
10/1244,600+₩20M-₩640M+₩10M+₩450M
10/847,550-₩320M-₩90M-₩330M+₩430M
10/749,400-₩20M+₩150M+₩30M+₩80M
10/650,900-₩120M+₩620M-₩90M-₩370M
10/248,450–-₩260M-₩30M+₩240M

Discussion

Google-verified members · return since posting
0/300

  1. Loading

세력 매집

last 60 trading days · Oct 19
Foreign 60D−₩6.9B
Pension funds 60D−₩2.2B
세력 Avg. cost43,862
vs. cost Close+2.5%

Foreign+Pension funds Total 시총의 -2.7%, 60D price 폭 60%·Chg +9.6%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.

세력 매집 구간 All →

Financial score

#411 of KOSPI 500
41.8/100
  • Value7.6
  • Quality10
  • Growth8
  • Financials6
  • Risk10.2
소외
All stock scores →

ETF

ETFs holding it in their top 10 · recent changes

10/08 이후 큰 ETF 변화는 없어요

All ETF index changes →

Recent filings

DART
  1. Loading

Broker price targets

Recent 1Y

Recent reports

  1. 콥데이 후기: 차세대 딜리버리 플랫폼에 주목SK Securities · 04/07

Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked

Same sector

  1. HLB
  2. PharmaResearch
  3. CLASSYS
  4. L&C BIO
  5. LivsMed
  6. SD Biosensor

Samyang Biopharm summary

Samyang Biopharm(0120G0). Pension funds last 20 trading days -₩650M. Market cap ₩334B, PER 24.13×, PBR 1.40×. Pension flows are based on Korea Exchange investor statistics, for reference only.